Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 2;21(5):723-729.
doi: 10.1002/cbic.201900428. Epub 2019 Nov 13.

Engineering of a Red Fluorogenic Protein/Merocyanine Complex for Live-Cell Imaging

Affiliations

Engineering of a Red Fluorogenic Protein/Merocyanine Complex for Live-Cell Imaging

Elizabeth M Santos et al. Chembiochem. .

Abstract

A reengineered human cellular retinol binding protein II (hCRBPII), a 15-kDa protein belonging to the intracellular lipid binding protein (iLBP) family, generates a highly fluorescent red pigment through the covalent linkage of a merocyanine aldehyde to an active site lysine residue. The complex exhibits "turn-on" fluorescence, due to a weakly fluorescent aldehyde that "lights up" with subsequent formation of a strongly fluorescent merocyanine dye within the binding pocket of the protein. Cellular penetration of merocyanine is rapid, and fluorophore maturation is nearly instantaneous. The hCRBPII/merocyanine complex displays high quantum yield, low cytotoxicity, specificity in labeling organelles, and compatibility in both cancer cell lines and yeast cells. The hCRBPII/merocyanine tag is brighter than most common red fluorescent proteins.

Keywords: hCRBPII; imaging; merocyanine; protein engineering; red fluorescence.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Merocyanine aldehyde 1 binds to an active site Lys residue to generate a red-shifted cyanine dye (POI = protein of interest).
Figure 2.
Figure 2.
Live-cell imaging of HeLa cells expressing EGFP-hCRBPIItetra (N-terminus attachment of hCRBPII) after incubation with 0.25 μM MCRA for 1 h at 37 °C followed by additional incubation in MCRA-free media for 0 min, 2 h, 4 h and 8 h. Live-cell imaging in HeLa cells expressing EGFP-hCRBPIItetraQ108L (N-terminus attachment of hCRBPII) serves as a control experiment without the reactive lysine. All samples were washed with PBS buffer twice before imaging. All confocal images are pseudocolored. All images were collected with a 40x oil immersed objective. MCRA/hCRBPII images in red were recorded using 594 nm laser and longpass (LP) filter 615 nm; all images in green were recorded with 488 nm laser and bandpass (BP) filter 505–530 nm. Scale bars are 20 μm.
Figure 3.
Figure 3.
Live-cell imaging of the COS-7, U2OS and HeLa cells expressing hCRBPIInona in the cytosol (EGFP-hCRBPIInona, N-terminus attachment of hCRBPII), labelled with 0.25 μM MCRA for 30 seconds. HeLa cells expressing EGFP-hCRBPIInona-3NLS and hCRBPIInona-NES were also labelled with 0.25 μM MCRA for 30 seconds (NLS and NES attached to C-terminus of hCRBPII). All samples were washed with PBS buffer twice and immediately imaged. All confocal images are pseudocolored. All images were collected with a 40x oil immersed objective. MCRA/hCRBPII images in red were recorded using 594 nm laser and LP filter 615 nm; all images in green were recorded with 488 nm laser and BP 505–530 nm. Scale bars are 20 μm.
Figure 4.
Figure 4.
Imaging of yeast cells expressing Fex1p fusion proteins; a. N-EGFP-Fex1-C; b. N-Fex1-EGFP-C; and c. N-Fex1-hCRBPIInona-C. Cells expressing N-Fex1-hCRBPIInona-C were incubated with 0.5 μM MCRA for 10 seconds, washed with water five times and then imaged. All confocal images are pseudocolored. All images were collected with a widefield microscope under white light. Scale bars are 10 μm.

References

    1. Bruchez MP, Curr. Opin. Chem. Biol. 2015, 27, 18–23; - PMC - PubMed
    2. Chudakov DM, Matz MV, Lukyanov S, Lukyanov KA, Physiol. Rev. 2010, 90, 1103–1163; - PubMed
    3. Day RN, Davidson MW, Chem. Soc. Rev. 2009, 38, 2887–2921; - PMC - PubMed
    4. Enterina JR, Wu L, Campbell RE, Curr. Opin. Chem. Biol. 2015, 27, 10–17; - PubMed
    5. Mishin AS, Belousov VV, Solntsev KM, Lukyanov KA, Curr. Opin. Chem. Biol. 2015, 27, 1–9; - PubMed
    6. Newman RH, Fosbrink MD, Zhang J, Chem. Rev. 2011, 111, 3614–3666; - PMC - PubMed
    7. K. Nienhaus G. U.Nienhaus, Chem. Soc. Rev. 2014, 43, 1088–1106; - PubMed
    8. Okumoto S, Jones A, Frommer WB, Annu. Rev. Plant Biol. 2012, 63, 663–706; - PubMed
    9. Shcherbakova DM, Verkhusha VV, Curr. Opin. Chem. Biol. 2014, 20, 60–68. - PMC - PubMed
    1. Landgraf D, Okumus B, Chien P, Baker TA, Paulsson J, Nat. Methods 2012, 9, 480–U498; - PMC - PubMed
    2. Wiedenmann J, Oswald F, Nienhaus GU, Iubmb Life 2009, 61, 1029–1042. - PubMed
    1. Griffin BA, Adams SR, Tsien RY, Science 1998, 281, 269–272; - PubMed
    2. Hoffmann C, Gaietta G, Zurn A, Adams SR, Terrillon S, Ellisman MH, Tsien RY, Lohse MJ, Nat. Protoc. 2010, 5, 1666–1677; - PMC - PubMed
    3. Jing C, Cornish VW, Acc. Chem. Res. 2011, 44, 784–792; - PMC - PubMed
    4. Scheck RA, Schepartz A, Acc. Chem. Res. 2011, 44, 654–665. - PMC - PubMed
    1. England CG, Luo H, Cai W, Bioconjugate Chem. 2015, 26, 975–986; - PMC - PubMed
    2. Liu DS, Phipps WS, Loh KH, Howarth M, Ting AY, ACS Nano 2012, 6, 11080–11087; - PMC - PubMed
    3. Los GV, Encell LP, McDougall MG, Hartzell DD, Karassina N, Zimprich C, Wood MG, Learish R, Ohane RF, Urh M, Simpson D, Mendez J, Zimmerman K, Otto P, Vidugiris G, Zhu J, Darzins A, Klaubert DH, Bulleit RF, Wood KV, ACS Chem. Biol. 2008, 3, 373–382; - PubMed
    4. Tseng J-C, Benink HA, McDougall MG, Chico-Calero I, Kung AL, Curr. Chem. Genomics 2012, 6, 48–54. - PMC - PubMed
    1. Jing C, Gallagher SS, Cornish VW, J. Gen. Physiol. 2010, 136, 8A–8A;
    2. Miller LW, Cai YF, Sheetz MP, Cornish VW, Nat. Methods 2005, 2, 255–257; - PubMed
    3. Jing C, Cornish VW, ACS Chem. Biol. 2013, 8, 1704–1712. - PMC - PubMed

Publication types

LinkOut - more resources